Duan W, Liu X, Jia J, Wang J, et al. The loss or absence of minimal residual disease of <0.1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis. Br J Haematol 2021;192:265-271.
PMID: 32588434